EUCRW
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
EUCRW
Delisted
EUCRW was delisted on the 26th of April, 2023.
3 hedge funds and large institutions have $601K invested in Eucrates Biomedical Acquisition Corp. Warrant in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
$335K
Puts
–
Net Calls
+$335K
Net Calls Change
+$335K
Top Buyers
| 1 |
SCM
1
Suvretta Capital Management
New York
|
$216K |
| 2 |
2
Hudson Bay Capital Management
Stamford,
Connecticut
|
$197K |
| 3 |
GPCM
3
Granite Point Capital Management
Boston,
Massachusetts
|
$188K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
1
Suvretta Capital Management
New York
| $216K | 33,333 | +33,333 | New |
|
|
2
Hudson Bay Capital Management
Stamford,
Connecticut
| $197K | 133,333 | +133,333 | New |
|
|
GPCM
3
Granite Point Capital Management
Boston,
Massachusetts
| $188K | 133,332 | +133,332 | New |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
RCM
5
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|